Improved Access to Innovative Drugs in Medicaid Program
This act aims to facilitate access to modern, often life-saving drugs within the Medicaid program. It introduces new payment rules that allow for drug billing based on their effectiveness, potentially reducing costs for the healthcare system and patients. This will make innovative therapies, such as gene therapies, more accessible to Medicaid beneficiaries.
Key points
Introduction of value-based payments for drugs in Medicaid, linking costs to actual effectiveness, potentially lowering treatment expenses.
Increased access to innovative therapies, including gene therapies, for patients covered by the Medicaid program.
Requirement for reporting drug prices under new payment systems, enhancing transparency and oversight of expenditures.
Expired
Citizen Poll